RACHEL SCHULZ: Open Payments
NPI 1205484771 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,300 in 50 payments from 17 companies in 2025. Trend: 2023 $887 · 2024 $920 · 2025 $2,300
Food & beverage: $2,211Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $628 |
| Incyte Corporation | 4 | $415 |
| Daiichi Sankyo Inc. | 6 | $266 |
| Syndax Pharmaceuticals, Inc. | 2 | $174 |
| PFIZER INC. | 1 | $125 |
| Stryker Corporation | 4 | $115 |
| ABBVIE INC. | 3 | $93 |
| Alexion Pharmaceuticals, Inc. | 1 | $90 |
| Celgene Corporation | 3 | $87 |
| BeOne Medicines USA, Inc. | 3 | $76 |
Products named: RYBREVANT, NIKTIMVO, Vanflyta, CARVYKTI, REVUFORJ, Monjuvi, FLOWTRIEVER CATHETER, S, SOLIRIS.
Industry payments across CA — which companies pay providers there.
